Advertisement

Journal of Zhejiang University-SCIENCE A

, Volume 3, Issue 4, pp 489–492 | Cite as

Effect of pretreatment with aspirin and ticlopidine on the change of platelet aggregability after radiofrequency catheter ablation

  • Wang Li-hong
  • Chen Jun-zhu
  • Zheng Lian-rong
  • Tao Qian-ming
Biotechnology & Lie Sciences
  • 30 Downloads

Abstract

Eighty-two patients with supraventricular tachycardia undergoing radiofrequency catheter ablation (RFCA) were studied to observe the inhibition effect of aspirin and ticlopidine on platelet aggregability (PAG) and thromboxane B2 (TXB2) of the blood samples. Patients were divided into aspirin group A, ticlopidine group B, aspirin + ticlopidine group C and control group D. PAG and TXB2 were increased clearly after RFCA in all groups (P<0.001). Treatment with aspirin or ticopidine before operation could reduce the platelet aggregability caused by RFCA and the joint effect of two drugs (change rate of group A: 52.51±12.51%; group B: 54.78±11.27%; group C: 30.51±10.59%; group D: 91.75±21.43%;P<0.05) was studied. The much decreased platelet aggregability after antiplatelet therapy was evidence of the potential benefit of the treatment in preventing thromboembolism after ablation. Pretreatment with aspirin and ticlopidine together is a good way to decrease palatelet aggregability after RFCA.

Key words

Catheter ablation Platelet aggregability Thromboxane B2 Aspirin Ticlopidine 

Document code

CLC number

R969.2 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anfinsen, O. G., Gjesdal, K., Brosstad, F., Orning, O. M., Aass, H., Kongsgaard, E., Amlie, J. P., 1999. The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients.J. Cardiovasc Electrophysiol,10: 503–512.CrossRefGoogle Scholar
  2. Manolis, A. S., Vassilikos, V., Maounis, T. N., Psarros, L., Melita-manolis, H., Papatheou, O., Haliassos, A., Christopoulou-Cokkinou, V., Cokkinos, D. V., 1997. Pretrentment with aspirin and tidopidine confers lower thrombogenic potential of radiofrequency catheter ablation.Am. J. Cardiol,79:494–497.CrossRefGoogle Scholar
  3. Manolis, A. S., Maounis, T., Vassilikos, V., Melitamanolis, H., Psarros, L., Terzoglou, G., Cokkinos, V. V., 1998. Pretreatment with antithrombotic agents during radiofrequency catheter ablation: a randomized comparison of aspirin versus ticlopidine.J. Cardiovasc Electrophysiol,9:1144–1151.CrossRefGoogle Scholar
  4. Harder, S., Klinkhardt, U., 2000. Thrombolytics: drug interactions of clinical significance.Drug Saf,23:391–399.CrossRefGoogle Scholar
  5. Wang, L. H., Zhu, J. H., Chen, J. Z., Zheng, L. R., Tao, Q. M., Zhang F. R., 2000. The function of pretreatment with aspirin and heparin to the change of platelet aggregebility after radiofrequency catheter ablation.Chinese Journal of Cardiology,18: 143 (in Chinese).Google Scholar
  6. Zhou, L., Keane, Mrcpi, D., Reed, G., Ruskin, J., 1999. Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions.J. Cardiovasc Electrophysiol,10:611–620.CrossRefGoogle Scholar

Copyright information

© Zhejiang University Press 2002

Authors and Affiliations

  • Wang Li-hong
    • 1
  • Chen Jun-zhu
    • 1
  • Zheng Lian-rong
    • 1
  • Tao Qian-ming
    • 1
  1. 1.The First Affiliated Hospital, College of MedicineZhejiang UniversityHanzhouChina

Personalised recommendations